Home / Resource Library / Ibrutinib Combo New Standard for Transplant-Ineligible Mantle Cell Lymphoma in Older PatientsIbrutinib Combo New Standard for Transplant-Ineligible Mantle Cell Lymphoma in Older Patients ASCO 2022